Evaluation of Vitamin A and Zinc Supplementation on Malarial Morbidity

NCT01782001 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2013-02-01

No results posted yet for this study

Summary

The purpose of this study was to determine whether young children receiving Vitamin A and Zinc supplements will have a lower incidence of symptomatic malaria than similar children receiving vitamin A supplements alone.

Conditions

Interventions

DIETARY_SUPPLEMENT

vitamin A

vitamin A with placebo

DIETARY_SUPPLEMENT

vitamin A and zinc

combination of vitamin A and zinc supplements

Sponsors & Collaborators

  • International Atomic Energy Agency

    collaborator OTHER_GOV
  • University of Wisconsin, Madison

    collaborator OTHER
  • Kintampo Health Research Centre, Ghana

    lead OTHER

Principal Investigators

  • Seth Owusu-Agyei, PhD · Kintampo Health Research Centre, Ghana

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • Ghana

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01782001 on ClinicalTrials.gov